Select Page
Developing treatments for chronic diseases
Select Page

Advisory Board

Amol Soin, M.D., M.B.A.

Chief Clinical Advisor

Dr. Soin is chairman and founder of The Ohio Pain Clinic- a network of free-standing chronic pain management facilities in southwestern Ohio focused on non opioid based treatments for chronic pain. He brings a wealth of experience in research, development, biotech angel investing, and regulatory matters to TheraVasc. Currently, he is a physician representative to Medicare via the Clinical Advisory Committee for Ohio and Kentucky. Additionally, he has held several key leadership positions in various statewide and national medical societies including President of the Ohio Society of Interventional Pain Physicians, President – Elect of TriState Pain Society and was appointed by Governor Kasich to the Ohio Medical Board in 2012 to a 5 year term. Dr. Soin has authored several papers, textbook chapters, abstracts, and served as a primary investigator for clinical research. He is also the founder and CEO of a biotech angel investment firm and has experience creating viable medical products from bench research. Dr. Soin serves as a Clinical Assistant Professor of Surgery at Wright State University Medical School. He was selected as one of America’s Top Doctors in Pain Management from 2006 – present, and has won multiple awards for research and patient care. He has also won the “Patients Choice Award”  and the “Top Doctors and Patient Choice Award”  multiple times for his region. Dr. Soin trained at the Cleveland Clinic, and currently he is an active practicing physician who sees patients that suffer from painful peripheral artery disease, diabetic neuropathy, and poor wound healing on a daily basis. He also serves as Chief Medical Officer and on the Board of Directors.

Brian H. Annex, M.D.

Clinical Advisor

Dr. Brian Annex is the Chief of the Division of Cardiovascular Medicine at the University of Virginia, and has had a long-standing clinical and basic research interest in the areas of angiogenesis and peripheral arterial disease (PAD). His group is conducting a series of translational studies in PAD, which include investigating the causes of lower extremity atherosclerosis, the mechanisms that regulate the control of collateral blood vessel formation, and the impact that diabetes mellitus plays in PAD. His group also performs computational modeling of growth factor pathways and investigates the genetic influences on the disease. Dr. Annex is regarded as a thought-leader in research and clinical trials in PAD.

Nagy Mekhail, M.D., Ph.D.

Clinical Advisor

Dr. Nagy Mekhail is Professor of Anesthesiology at the Cleveland Clinic Lerner College of Medicine, and holds a joint appointment at the Cleveland Clinic Spine Center and the Cleveland Clinic Cancer Center. His areas of specialty include evaluation of back and neck pain, interventional pain management for back and neck pain, management of spinal stenosis and vertebral compression fractures, as well as cancer and neuropathic pain evaluation and management. Dr. Mekhail is the Chair of the Interventional Pain Practice Examination Board, a member of the American Society of Anesthesiologists Pain Committee Chair of the Interventional Pain Practice Examination Board, Associate Editor of Regional Anesthesia and pain Medicine Journal, and a member of the World Institute of Pain Executive Board.

Edgar Ross, M.D.

Clinical Advisor

Dr. Edgar Ross is the Director of the Pain Management Center at Harvard Medical School and Assistant Professor of Medicine. Dr. Ross is board certified in Anesthesiology and Pain Management, and specializes in vascular pain. Dr. Ross studied at the Wayne State University School of Medicine and completed his residency and fellowship at the University Hospitals of Cleveland.

Douglas Flanagan, Ph.D.

Chief Formulation Advisor

Dr. Flanagan is a Professor of Pharmaceutics and Chemical & Biochemical Engineering and former Division Head of the Pharmaceutics Division in the College of Pharmacy at the University of Iowa. With nearly 90 publications and over 100 presentations at scientific meetings, Dr. Flanagan has 40 years experience teaching about and developing drug formulations and biopharmaceutics. He has had numerous collaborative grants with government agencies and partnerships with pharmaceutical companies such as Bristol-Myers Squibb, Abbott Laboratories, Axonyx, and over 25 other firms, working on controlled drug delivery systems and formulations. Many of these collaborative efforts and partnerships have come through his over 30 year relationship with the University of Iowa Pharmaceuticals (UIP). UIP is a FDA-registered clinical manufacturer which has provided to formulation development and production services to the pharmaceutical industry and government agencies for over 40 years.

Michael Gill

Regulatory Advisor

Mr. Gill is a Regulatory, QA, QC Compliance Consultant with an extensive knowledge of quality assurance, cGLP, cGMP quality control systems, chemistry, manufacturing and controls requirements, and an expert in general FDA Regulatory requirements with 26 years of experience in the U.S. pharmaceutical industry working for international pharmaceutical companies. Mr. Gill began his career as an analytical chemist for Boots Pharmaceuticals, Inc., then transitioned into the Regulatory Affairs department where he worked in the R&D group managing INDs for the cardiovascular and anti-depressant drug product portfolios. Mr. Gill then worked as a Regulatory and Compliance Manager for BASF Corportion, the US subsidiary of the German chemical company and subsequently as a Regulatory and Compliance Manager for Dr. Reddys Laboratories, Inc., an Indian based generic drug leader in the world generic market. Mr. Gill successfully lead transition teams for the introduction of foreign manufactured drug product and transfer of the manufacturing of those products from foreign plants to US manufacturing facilities for the US market for oral solutions, creams and solid oral dosage forms. Mr. Gill has had extensive experience in managing US FDA, EU and German regulatory authority inspections for US manufacturing facilities.

Lokesh B Ningegowda, MD

Clinical Advisor

Dr. Lokesh Ningegowda is a pain management physician practicing in the Cleveland area. He is a consultant for interventional pain management at NIA Magellan. He is board certified in Anesthesiology and Pain Medicine. His field of interest includes interventional pain management for treatment of spinal conditions, neuropatic pain and neuromodulation. He completed his Anesthesiology residency and Pain Medicine Fellowship at Cleveland Clinic and subsequently served as faculty in the Department of Pain Management, Anesthesia Institute at the Cleveland Clinic for several years. He was also the Department Director for Pain Management at Cleveland Clinic’s Twinsburg Family Health and Surgical Center. He has membership in various professional organizations and has an avid interest in teaching. Dr. Ningegowda has presented in various national and international Pain Management conferences. He has been an instructor in many national and international workshops and has trained many physicians on various techniques of interventional pain procedures. He has authored several text book chapters on pain management, abstracts and has been involved in clinical research.

Syed Ali, M.D.

Clinical Advisor

Dr. Syed Ali is a pain physician at Western Reserve Hospital in Akron Ohio. He is board certified in Anesthesiology and Pain Management and is a clinical associate professor of anesthesiology at Ohio University College of Medicine and clinical assistant professor of surgery at Northeast Ohio Medical University. His specialty interests include low back and neuropathic pain. He serves as the consultant team pain physician for the University of Akron and Kent State University athletic teams. Dr. Ali studied at the Ohio State University School of Medicine and completed his residency and fellowship at Cleveland Clinic.